CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 42 enrolled
Drug / intervention
LY900014 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03760640
NCT03760640Phase 2Completed
CompareCT.gov

Evaluation of LY900014 in a Medtronic Pump

Eli Lilly and Company·interventional·Posted Nov 30, 2018·Updated Oct 29, 2020

In Brief

A Phase 2 clinical trial evaluating LY900014 and Insulin Lispro for Type1 Diabetes Mellitus. Completed, enrolled 42 participants across 2 sites.

Detailed Summary

The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes (T1D). The study will consist of two treatment periods of 4 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType1 Diabetes Mellitus
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedNov 30, 2018
Enrollment StartFeb 18, 2019
Primary CompletionOct 7, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.6 years ago

Interventions

LY900014drug

Administered SC

Insulin Lisprodrug

Administered SC